bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.7037
-0.0081 (-1.14%)
At close: Jul 17, 2026, 4:00 PM EDT
0.7001
-0.0036 (-0.51%)
After-hours: Jul 17, 2026, 7:44 PM EDT
bioAffinity Technologies Employees
bioAffinity Technologies had 57 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
57
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$99,296
Profits / Employee
-$278,596
Market Cap
3.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57 | 0 | - |
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Burning Rock Biotech | 667 |
| MDxHealth | 364 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| Insight Molecular Diagnostics | 58 |
| Advanced Biomed | 31 |
| Quantum Cyber | 13 |
BIAF News
- 10 days ago - BioAffinity Technologies’ CyPath Lung diagnostic sales double in Q2 - TheFly
- 10 days ago - bioAffinity Technologies' Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues - Business Wire
- 25 days ago - BioAffinity will present preclinical findings on small interfering RNAs - TheFly
- 25 days ago - bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells - Business Wire
- 4 weeks ago - WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering - PRNewsWire
- 4 weeks ago - bioAffinity Technologies Announces Closing of $3.2 Million Offering - Business Wire
- 4 weeks ago - WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering - PRNewsWire
- 4 weeks ago - BioAffinity Technologies prices 4M shares at 80c in public offering - TheFly